Prashad Sacha Leandra, Calvanese Vincenzo, Yao Catherine Yao, Kaiser Joshua, Wang Yanling, Sasidharan Rajkumar, Crooks Gay, Magnusson Mattias, Mikkola Hanna Katri Annikki
Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA; Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Cell Stem Cell. 2015 Jan 8;16(1):80-7. doi: 10.1016/j.stem.2014.10.020. Epub 2014 Nov 13.
Advances in pluripotent stem cell and reprogramming technologies have given us the hope of generating hematopoietic stem cells (HSCs) in culture. To succeed, greater understanding of the self-renewing HSC during human development is required. We discovered that the glycophosphatidylinositol-anchored surface protein GPI-80 defines a subpopulation of human fetal liver hematopoietic stem/progenitor cells (HSPCs) with self-renewal ability. CD34(+)CD38(lo/-)CD90(+)GPI-80(+) HSPCs were the sole population that maintained proliferative potential and an undifferentiated state in stroma coculture and engrafted in immunodeficient mice. GPI-80 expression also enabled tracking of HSPCs once they emerged from endothelium and migrated between human fetal hematopoietic niches. GPI-80 colocalized on the surface of HSPCs with Integrin alpha-M (ITGAM), which in leukocytes cooperates with GPI-80 to support migration. Knockdown of GPI-80 or ITGAM was sufficient to compromise HSPC expansion in culture and engraftment in vivo. These findings indicate that human fetal HSCs employ mechanisms used in leukocyte adhesion and migration to mediate HSC self-renewal.
多能干细胞和重编程技术的进展让我们有望在体外培养中生成造血干细胞(HSC)。要取得成功,需要更深入地了解人类发育过程中自我更新的造血干细胞。我们发现,糖基磷脂酰肌醇锚定表面蛋白GPI-80定义了具有自我更新能力的人类胎儿肝脏造血干/祖细胞(HSPC)亚群。CD34(+)CD38(lo/-)CD90(+)GPI-80(+) HSPC是唯一在基质共培养中保持增殖潜力和未分化状态并能植入免疫缺陷小鼠体内的细胞群体。一旦HSPC从内皮细胞中出现并在人类胎儿造血微环境之间迁移,GPI-80表达还能对其进行追踪。GPI-80与整合素α-M(ITGAM)在HSPC表面共定位,在白细胞中,ITGAM与GPI-80协同支持迁移。敲低GPI-80或ITGAM足以损害HSPC在培养中的扩增以及在体内的植入。这些发现表明,人类胎儿造血干细胞利用白细胞黏附和迁移中使用的机制来介导造血干细胞自我更新。